Jack A. Khattar, Director of Cognition Therapeutics CGTX, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $7.2M. The latest trade was on 06/17.

JK

JK

Jack A. Khattar

Director

Company

Cognition Therapeutics CGTX

First filing

23/01/13

Trades

157 trades

Buys / sales

0 / 28

12-month net buying

−$7.2M

Last trade

06/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	03/13	03/16	35,000 sh3 trades	$50.37avg.	$1,763,124.42	−3.5%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/10/09	25/10/10	59,900 sh2 trades	$50.57avg.	$3,029,336.39	−4.7%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/10/02	25/10/03	1,904 sh	$48.06	$91,506.24	−0.2%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/10/01	25/10/02	40,173 sh	$48.07	$1,931,116.11	−3.3%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/09/30	25/10/01	8,588 sh	$48.25	$414,371	−0.7%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/09/29	25/09/30	10,235 sh	$48.02	$491,484.7	−0.9%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/09/23	25/09/24	29,513 sh	$47.23	$1,393,898.99	−2.5%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/09/22	25/09/23	16,587 sh	$47.02	$779,920.74	−1.5%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/09/08	25/09/09	6,322 sh	$46.29	$292,645.38	−0.6%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/09/05	25/09/08	55,578 sh	$46.01	$2,557,143.78	−4.8%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/27–25/08/28	25/08/29	34,800 sh2 trades	$45.10avg.	$1,569,430.5	−3.1%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/25	25/08/27	1,000 sh	$45.00	$45,000	−0.1%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/22	25/08/26	1,500 sh	$45.00	$67,500	−0.1%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/08/06	25/08/08	140,000 sh3 trades	$42.02avg.	$5,883,360	−11.6%
Supernus PharmaceuticalsSUPN	Open-market sale	24/11/08	24/11/12	125,000 sh	$36.29	$4,536,250	−11.9%
Supernus PharmaceuticalsSUPN	Open-market sale	24/11/07	24/11/08	125,000 sh	$36.68	$4,585,000	−11.9%
Supernus PharmaceuticalsSUPN	Open-market sale	23/02/02–23/02/03	23/02/06	13,732 sh2 trades	$42.06avg.	$577,559.92	No record
Supernus PharmaceuticalsSUPN	Open-market sale	23/02/01	23/02/03	300 sh	$42.01	$12,603	−0.0%
Supernus PharmaceuticalsSUPN	Open-market sale	23/01/31	23/02/02	976 sh	$42.01	$41,001.76	−0.1%
Supernus PharmaceuticalsSUPN	Open-market sale	23/01/18	23/01/20	4,936 sh	$40.40	$199,414.4	−0.6%